Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct;38(10):1921-9.
doi: 10.2337/dc14-2732. Epub 2015 Jul 15.

Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration

Affiliations
Review

Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration

Matthias W Lorenz et al. Diabetes Care. 2015 Oct.

Abstract

Objective: Carotid intima-media thickness (CIMT) is a marker of subclinical organ damage and predicts cardiovascular disease (CVD) events in the general population. It has also been associated with vascular risk in people with diabetes. However, the association of CIMT change in repeated examinations with subsequent CVD events is uncertain, and its use as a surrogate end point in clinical trials is controversial. We aimed at determining the relation of CIMT change to CVD events in people with diabetes.

Research design and methods: In a comprehensive meta-analysis of individual participant data, we collated data from 3,902 adults (age 33-92 years) with type 2 diabetes from 21 population-based cohorts. We calculated the hazard ratio (HR) per standard deviation (SD) difference in mean common carotid artery intima-media thickness (CCA-IMT) or in CCA-IMT progression, both calculated from two examinations on average 3.6 years apart, for each cohort, and combined the estimates with random-effects meta-analysis.

Results: Average mean CCA-IMT ranged from 0.72 to 0.97 mm across cohorts in people with diabetes. The HR of CVD events was 1.22 (95% CI 1.12-1.33) per SD difference in mean CCA-IMT, after adjustment for age, sex, and cardiometabolic risk factors. Average mean CCA-IMT progression in people with diabetes ranged between -0.09 and 0.04 mm/year. The HR per SD difference in mean CCA-IMT progression was 0.99 (0.91-1.08).

Conclusions: Despite reproducing the association between CIMT level and vascular risk in subjects with diabetes, we did not find an association between CIMT change and vascular risk. These results do not support the use of CIMT progression as a surrogate end point in clinical trials in people with diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Forest plot of HR of the combined end point (MI, stroke, or vascular death) per SD of average mean CCA-IMT in subjects with diabetes. Note that pooled small studies included Atherosclerosis and Insulin Resistance study (AIR); CAPS; Chinese Multi-provincial Cohort Study (CMCS); Diabetes, Impaired glucose tolerance in Women and Atherosclerosis (DIWA); Edinburgh Artery Study (EAS); Estudio epidemiológico sobre enfermedades y factores de riesgo cardiovasculares en ancianos españoles (EPICARDIAN); Kuopio Ischaemic Heart Disease study (KIHD); NOMAS/INVEST; Progression of Lesions in the Intima of the Carotid (PLIC); and Salzburg Atherosclerosis Prevention program in subjects at High Individual Risk (SAPHIR).
Figure 2
Figure 2
Forest plot of HR of the combined end point (MI, stroke, or vascular death) per SD of annual mean CCA-IMT progression in subjects with diabetes. Note that pooled small studies included Atherosclerosis and Insulin Resistance study (AIR); CAPS; Chinese Multi-provincial Cohort Study (CMCS); Diabetes, Impaired glucose tolerance in Women and Atherosclerosis (DIWA); Edinburgh Artery Study (EAS); Estudio epidemiológico sobre enfermedades y factores de riesgo cardiovasculares en ancianos españoles (EPICARDIAN); NOMAS/INVEST; Progression of Lesions in the Intima of the Carotid (PLIC); and Salzburg Atherosclerosis Prevention program in subjects at High Individual Risk (SAPHIR).

References

    1. Sarwar N, Gao P, Seshasai SRK, et al. .; Emerging Risk Factors Collaboration . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies [published correction appears in Lancet 2010;376:958]. Lancet 2010;375:2215–2222 - PMC - PubMed
    1. Woodward M, Zhang X, Barzi F, et al. .; Asia Pacific Cohort Studies Collaboration . The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 2003;26:360–366 - PubMed
    1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229–234 - PubMed
    1. Wagenknecht LE, D’Agostino RB Jr, Haffner SM, Savage PJ, Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care 1998;21:1812–1818 - PubMed
    1. Temelkova-Kurktschiev TS, Koehler C, Leonhardt W, et al. . Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care 1999;22:333–338 - PubMed